Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
Clinical trial NCT04992949 · COMPLETED
Trial details
- NCT number
- NCT04992949
- Sponsor
- French Innovative Leukemia Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2023-10-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.